NEURONS INC. ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  7.2% 11.0% 3.7% 4.5% 8.4%  
Credit score (0-100)  35 22 50 46 28  
Credit rating  BBB BB BBB BBB BB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 -0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Gross profit  9.8 3.4 10,704 9,797 18,609  
EBITDA  0.9 -2.0 -3,300 -24,723 -26,098  
EBIT  0.8 -2.0 -3,493 -27,022 -30,293  
Pre-tax profit (PTP)  0.8 -2.1 -3,694.3 -27,753.7 -32,909.6  
Net earnings  0.6 -1.7 -3,628.0 -25,708.9 -30,577.3  
Pre-tax profit without non-rec. items  0.8 -2.1 -3,694 -27,754 -32,910  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  0.2 0.2 1,040 819 580  
Shareholders equity total  2.4 8.3 4,628 17,786 -12,791  
Interest-bearing liabilities  0.1 7.2 7,621 7,706 26,181  
Balance sheet total (assets)  5.4 17.2 16,724 39,093 35,037  

Net Debt  -2.0 -7.7 6,963 -4,993 25,443  
 
See the entire balance sheet

Volume 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  9.8 3.4 10,704 9,797 18,609  
Gross profit growth  -11.7% -65.6% 317,726.0% -8.5% 89.9%  
Employees  23 13 28 61 75  
Employee growth %  0.0% -43.5% 115.4% 117.9% 23.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  5 17 16,724 39,093 35,037  
Balance sheet change%  -34.4% 221.9% 96,854.4% 133.8% -10.4%  
Added value  0.9 -2.0 -3,299.7 -26,828.7 -26,097.6  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -0 -0 4,978 9,120 2,210  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  4.0 -1.0 -2.0 -3.0 -4.0  

Profitability 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  7.8% -60.7% -32.6% -275.8% -162.8%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  11.4% -18.0% -39.1% -96.4% -69.5%  
ROI %  27.5% -22.6% -53.4% -142.6% -117.0%  
ROE %  21.4% -31.2% -156.5% -229.4% -115.8%  

Solidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  45.2% 47.9% 27.7% 45.5% -26.7%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -215.7% 389.7% -211.0% 20.2% -97.5%  
Gearing %  4.6% 87.0% 164.7% 43.3% -204.7%  
Net interest  0 0 0 0 0  
Financing costs %  14.8% 2.4% 11.0% 11.1% 15.9%  

Liquidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  1.7 8.4 2.3 1.6 0.3  
Current Ratio  1.7 8.4 2.3 1.6 0.3  
Cash and cash equivalent  2.1 14.9 658.5 12,698.2 738.1  

Capital use efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  2.2 15.0 6,218.0 8,258.5 -21,446.0  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 -0 -118 -440 -348  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 -0 -118 -405 -348  
EBIT / employee  0 -0 -125 -443 -404  
Net earnings / employee  0 -0 -130 -421 -408